“Increasing Use of Bioactive and Resorbable Materials”
- One prominent trend in the global bone void filler market is the increasing use of bioactive and resorbable materials
- These advanced fillers promote better bone regeneration by actively interacting with the surrounding bone tissue, enhancing healing and integration
- For instance, In March 2025, Elute, Inc. received U.S. Food and Drug Administration (FDA) approval for BonVie+, a novel synthetic resorbable bone void filler implant. BonVie+ is designed to fill bone defects and is gradually replaced by new bone over time, promoting natural healing
- Resorbable materials, on the other hand, gradually degrade over time, eliminating the need for secondary surgeries to remove the filler, making them more appealing for both patients and surgeons
- This trend is improving patient outcomes by providing more effective, longer-lasting treatments, reducing recovery times, and lowering the risk of adverse reactions, which is fueling the growth of the bone void filler market
